Specialty Pharmacy To Pay $13M To Settle False Claims Suit Over Chelation Drug
NEW YORK — Specialty pharmacy US Bioservices Corp. (US Bio) will pay $13.4 million to settle the federal government’s allegations about US Bio’s role in a Novartis Pharmaceuticals Corp. scheme to...To view the full article, register now.
Already a subscriber? Click here to view full article